Amedeo Smart

Free Medical Literature Service

 

Amedeo

Autoimmune Disorders
  Free Subscription

31.08.2026

1 BMC Neurol
2 Brain
2 Diabet Med
1 J Autoimmun
4 J Neurol
4 Mult Scler
1 Neurology
1 PLoS Biol
2 PLoS One
1 Proc Natl Acad Sci U S A


    BMC Neurol

  1. KOLSCHE T, Hagler R, Huntemann N, Masanneck L, et al
    Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.
    BMC Neurol. 2026;26:536.
    >> Share


    Brain

  2. FOSTER MA, Wade C, Ford HL, Schmierer K, et al
    Diagnosing multiple sclerosis: implementation and unintended effects of the 2024 McDonald criteria.
    Brain. 2026 Aug 28:awag293. doi: 10.1093.
    >> Share

  3. GRUT V, Ingvarsson J, Bistrom M, Jons D, et al
    Lytic Epstein-Barr virus infection and emerging autoantibodies precede multiple sclerosis prodrome.
    Brain. 2026 Aug 22:awag283. doi: 10.1093.
    >> Share


    Diabet Med

  4. DESAI SS, Malik MMUD
    Comment on 'Improved prediction of symptomatic type 1 diabetes using a luciferase-based assay to measure (pro) insulin autoantibodies'.
    Diabet Med. 2026 Aug 28:e70462. doi: 10.1111/dme.70462.
    >> Share

  5. WYATT RC, Brigatti C, Grace SL, Williams CL, et al
    In response to comment on improved prediction of symptomatic type 1 diabetes using a luciferase-based assay to measure (pro) insulin autoantibodies.
    Diabet Med. 2026 Aug 28:e70471. doi: 10.1111/dme.70471.
    >> Share


    J Autoimmun

  6. LOU H, Zhang M, Zhang B, Lu Q, et al
    Multimodal computational framework resolves B cell maturation in autoimmunity and ageing.
    J Autoimmun. 2026;163:103609.
    >> Share


    J Neurol

  7. JIANG M, Rubin M, Storelli L, Grosselle M, et al
    Subjective sleep disturbances are associated with reduced MRI-derived perivascular-space diffusivity in multiple sclerosis.
    J Neurol. 2026;273:538.
    >> Share

  8. DE MAURO A, Cortese R, Fadda G, De Stefano N, et al
    Central vein sign and paramagnetic rim lesions in pediatric-onset multiple sclerosis: a systematic review and meta-analysis.
    J Neurol. 2026;273:540.
    >> Share

  9. CRISCUOLO V, Nicolella V, Polito C, Sirica R, et al
    Real-world Roche Elecsys((R)) and Fujirebio Lumipulse((R)) inter-platform comparability and clinical validation of plasma neurofilament light chain in multiple sclerosis.
    J Neurol. 2026;273:546.
    >> Share

  10. PENG HH, Nhu NT, Hou WH
    Effectiveness of vestibular rehabilitation in patients with multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials.
    J Neurol. 2026;273:553.
    >> Share


    Mult Scler

  11. GROMISCH ES, Foley FW, Wagshul ME, Holtzer R, et al
    Affective reserve in older adults with and without multiple sclerosis: A residual-based approach.
    Mult Scler. 2026 Aug 28:13524585261480508. doi: 10.1177/13524585261480508.
    >> Share

  12. GILMORE S, Poole S, Henderson K, Sisodia N, et al
    Persistent differences in initial diagnostic trajectory for Black and Hispanic individuals presenting with multiple sclerosis between 2020 and 2023.
    Mult Scler. 2026 Aug 23:13524585261475041. doi: 10.1177/13524585261475041.
    >> Share

  13. SWETLIK C, Parikh S, Abrams A, Bhayana K, et al
    Taking another look: LBSL diagnosed in adulthood masquerading as multiple sclerosis.
    Mult Scler. 2026 Aug 22:13524585261477212. doi: 10.1177/13524585261477212.
    >> Share

  14. MONTOBBIO N, Bovis F, Hofer L, Haring DA, et al
    A community-validated tool for clinical outcome calculation in multiple sclerosis: Consensus development and scenario-specific recommendations.
    Mult Scler. 2026 Aug 22:13524585261478492. doi: 10.1177/13524585261478492.
    >> Share


    Neurology

  15. HACOHEN Y, Androdias G, Arrambide G, Bruijstens AL, et al
    De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.
    Neurology. 2026;107:e218482.
    >> Share


    PLoS Biol

  16. CUNHA C, Inacio D, Romero PV, Pais AT, et al
    A microRNA atlas of CD4+ T cell subsets in experimental autoimmune encephalomyelitis identifies regulators of disease pathogenesis.
    PLoS Biol. 2026;24:e3003271.
    >> Share


    PLoS One

  17. CHAIPRASERT A, Han P, Laomettachit T, Ruengjitchatchawalya M, et al
    Phycocyanobilin: A potential bioactive compound from Arthrospira platensis targeting LYN protein associated with systemic lupus erythematosus.
    PLoS One. 2026;21:e0357093.
    >> Share

  18. SUN B, Lu Y, Liu W, Wang C, et al
    Systems pharmacology reveals type I interferon and myeloid-like B cell reprogramming as candidate druggable axes in antiphospholipid syndrome.
    PLoS One. 2026;21:e0349155.
    >> Share


    Proc Natl Acad Sci U S A

  19. ARCO-HIERVES A, Pamboukas K, Bilonda Mutala L, Borowski LS, et al
    Loss of epitranscriptomic mitochondrial RNA surveillance drives epithelial type I interferon and inflammation in autoimmunity.
    Proc Natl Acad Sci U S A. 2026;123:e2534325123.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016